Hyperinsulinism is a topic covered in the Select 5-Minute Pediatrics Topics.

To view the entire topic, please or purchase a subscription.

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

Medicine Central

-- The first section of this topic is shown below --

Basics

Description

Hyperinsulinism (HI) is a disorder of dysregulated insulin secretion resulting in hypoglycemia. Congenital HI refers to a permanent inborn condition, other forms can be transient.

Epidemiology

Most common cause of persistent or recurrent hypoglycemia in children

Incidence

  • Annual incidence estimated at ∼1:40,000–50,000 live births in United States.
  • May be as high as 1:2,500 in select populations (Saudi Arabians, Ashkenazi Jews)

Genetics

  • KATPHI: inactivating mutations in KATP channel genes ABCC8 and KCNJ11 (on 11p15)
    • Mutations inherited in an autosomal recessive manner result in diffuse involvement throughout the pancreas (diffuse HI).
    • Autosomal dominantly inherited mutations can also rarely cause diffuse HI.
    • Non-Mendelian inheritance: A paternally inherited recessive mutation of KATP channel gene and a loss of maternal alleles on the imprinted chromosome region 11p15, leads to paternal uniparental disomy; results in focal adenomatous lesion (focal HI)
  • Glucokinase-HI: autosomal dominant–activating mutations of glucokinase (GCK)
  • GDH-HI: autosomal dominant–activating mutations of glutamate dehydrogenase (GDH), encoded by GLUD1; known as hyperinsulinism/hyperammonemia (HI/HA) syndrome
  • SCHAD-HI: autosomal recessive mutations of mitochondrial enzyme short-chain-3-hydroxyacyl-CoA dehydrogenase (SCHAD), encoded by HADH
  • UCP2-HI: autosomal dominant mutations of mitochondrial carrier uncoupling protein 2 (UCP2), encoded by UCP2
  • HNF4A and HNF1A-HI: autosomal dominant mutations in transcription factors, HNF4A and HNF1A. Mutations in HNF4A and HNF1A also are known to cause familial monogenic diabetes.
  • MCT1-HI: autosomal dominant mutations in the regulatory region of SLC16A1–encoding monocarboxylate transporter 1 (MCT1)
    • Causes exercise-induced HI

Pathophysiology

  • These mutations result in uncoupling of insulin secretion from the glucose-sensing machinery of the pancreatic β cell.
    • Leads to inappropriate insulin secretion even in the face of low plasma glucose concentrations
    • In the absence of functional KATP channels, plasma membrane is depolarized leading to opening of voltage-dependent calcium channels and constant insulin secretion.
  • In the focal form of the disease (∼60% of cases), a cluster of pancreatic β cells are affected, whereas in diffuse HI, all β cells are abnormal.
  • In HI/HA syndrome, activating mutations of GDH (an enzyme that regulates amino acid–stimulated insulin secretion) cause dysregulated insulin secretion (particularly after ingestion of protein) and persistently elevated ammonia levels.
  • Glucokinase acts as “glucose sensor” of the β cell. Activating mutations result in lower glucose threshold for insulin secretion.
  • SCHAD is an inhibitory regulator of GDH. Inactivating mutations of HADH result in insulin dysregulation due to loss of GDH inhibition.
  • UCP2 is a negative regulator of insulin secretion. Loss-of-function mutations lead to HI.
  • In exercise-induced HI, ectopic expression of MCT1 allows transport of pyruvate, elevated during anaerobic exercise, into the β cell; leads to an increased ATP-to-ADP ratio, thus stimulating insulin secretion

Etiology

  • Mutations in 9 genes have been associated with congenital HI: Genes coding for the two subunits of the β cell KATP channel [SUR1, sulfonylurea receptor (ABCC8); Kir6.2, inwardly rectifying potassium channel (KCNJ11)]; glucokinase (GCK), glutamate dehydrogenase (GLUD1), SCHAD (HADH), UCP2 (UCP2), HNF4A, HNF1A and monocarboxylate transporter-1 (SLC16A1).
  • A transient form of HI has been associated with perinatal stress (small for gestational age [SGA] birth weight, maternal hypertension, precipitous delivery, or hypoxia), but the mechanism has not been elucidated.

Commonly Associated Conditions

HI can be associated with Beckwith-Wiedemann syndrome and congenital disorders of glycosylation (CDG). The underlying mechanism of HI in these disorders is not clear.

-- To view the remaining sections of this topic, please or purchase a subscription --

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Hyperinsulinism ID - 14152 Y1 - 2015 PB - Select 5-Minute Pediatrics Topics UR - https://im.unboundmedicine.com/medicine/view/Select-5-Minute-Pediatric-Consult/14152/all/Hyperinsulinism ER -